(HCC) Warrior Met Coal - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US93627C1018
HCC: Metallurgical Coal, Natural Gas
Warrior Met Coal Inc, listed on the New York Stock Exchange under the ticker symbol HCC, is a key player in the global metallurgical coal market, focusing on the production and export of high-quality, non-thermal steelmaking coal. This type of coal is essential for metal manufacturers in various regions, including Europe, South America, and Asia, where it is used in the steel production process. The company's coal products are primarily hard-coking coal, which is extracted through the operation of underground mines located in Alabama, a region known for its rich coal deposits.
The company's operations are not limited to coal production alone; it also engages in the sale of natural gas, which is extracted as a byproduct of the coal mining process. This diversification allows Warrior Met Coal Inc to capitalize on additional revenue streams, enhancing its overall profitability. With its incorporation in 2015, the company has established itself as a significant entity in the coal and natural gas sector, with its headquarters situated in Brookwood, Alabama. For more information, the company's official website can be accessed at https://warriormetcoal.com, providing insights into its operations, products, and mission.
From an investment perspective, Warrior Met Coal Inc is categorized as a common stock, with the ISIN code US93627C1018. It falls under the GICS Sub Industry classification of Steel, reflecting its core business of supplying critical raw materials to the steel production industry. This classification is crucial for investors looking to diversify their portfolios within the metals and mining sector, particularly those interested in companies that contribute to the global steel supply chain. The company's specific focus on metallurgical coal distinguishes it within the broader energy and natural resources market, offering a unique investment opportunity for those seeking exposure to this niche segment.
Additional Sources for HCC Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
HCC Stock Overview
Market Cap in USD | 2,737m |
Sector | Basic Materials |
Industry | Coking Coal |
GiC Sub-Industry | Steel |
IPO / Inception | 2017-04-13 |
HCC Stock Ratings
Growth 5y | 74.3% |
Fundamental | 47.9% |
Dividend | 57.8% |
Rel. Strength Industry | -251 |
Analysts | 4/5 |
Fair Price Momentum | 60.43 USD |
Fair Price DCF | 18.94 USD |
HCC Dividends
Dividend Yield 12m | 1.43% |
Yield on Cost 5y | 4.57% |
Annual Growth 5y | 32.60% |
Payout Consistency | 74.6% |
HCC Growth Ratios
Growth Correlation 3m | -62.3% |
Growth Correlation 12m | -2.8% |
Growth Correlation 5y | 96% |
CAGR 5y | 26.08% |
CAGR/Mean DD 5y | 1.59 |
Sharpe Ratio 12m | -0.24 |
Alpha | -34.65 |
Beta | 0.66 |
Volatility | 41.94% |
Current Volume | 465.3k |
Average Volume 20d | 714.8k |
As of January 22, 2025, the stock is trading at USD 57.16 with a total of 465,306 shares traded.
Over the past week, the price has changed by +6.94%, over one month by +4.14%, over three months by -6.40% and over the past year by -15.74%.
Partly, yes. Based on ValueRay Fundamental Analyses, Warrior Met Coal (NYSE:HCC) is currently (January 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 47.85 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HCC as of January 2025 is 60.43. This means that HCC is currently overvalued and has a potential downside of 5.72%.
Warrior Met Coal has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy HCC.
- Strong Buy: 3
- Buy: 0
- Hold: 3
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, HCC Warrior Met Coal will be worth about 66.2 in January 2026. The stock is currently trading at 57.16. This means that the stock has a potential upside of +15.89%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 75 | 31.2% |
Analysts Target Price | 77 | 34.7% |
ValueRay Target Price | 66.2 | 15.9% |